Drugmaker Cipla
Cipla, India's fifth largest drugmaker by sales, had last year offered to buy 51 percent equity in Cipla Medpro for $215 million at 8.55 rands a share. Cipla has now raised the price to 10 rands a share, it said in a statement.
The Indian drugmaker's Chairman Y. K. Hamied had said early this month the company had put the deal on hold.
Shares in Cipla were up 0.8 percent at Rs 367.40 by 0346 GMT when the Mumbai market was up 0.88 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.